Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:19 pm Unchanged | 2024-02-14 | 13G | Voyager Therapeutics, Inc. VYGR | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:19 pm Unchanged | 2024-02-14 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:15 pm Unchanged | 2024-02-14 | 13G | Pliant Therapeutics, Inc. PLRX | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:08 pm Unchanged | 2023-02-14 | 13G | Pliant Therapeutics, Inc. PLRX | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:07 pm Unchanged | 2023-02-14 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:04 pm Unchanged | 2023-02-14 | 13G | Nurix Therapeutics, Inc. NRIX | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:03 pm Unchanged | 2023-02-14 | 13G | Revolution Medicines, Inc. Warrant RVMDW | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:02 pm Unchanged | 2023-02-14 | 13G | Voyager Therapeutics, Inc. VYGR | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:06 pm Unchanged | 2022-02-14 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:03 pm Unchanged | 2022-02-14 | 13G | Decibel Therapeutics, Inc. DBTX | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:02 pm Unchanged | 2022-02-14 | 13G | Revolution Medicines, Inc. Warrant RVMDW | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:57 pm Unchanged | 2022-02-14 | 13G | Nurix Therapeutics, Inc. NRIX | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:52 pm Unchanged | 2022-02-14 | 13G | Relay Therapeutics, Inc. RLAY | Third Rock Ventures III L.P. | 0 0.000% | 0 (Unchanged) | Filing |